Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exsiva Pharma markets a broad portfolio of branded generic medicines and nutraceuticals in India across several therapeutic areas including ENT, neurology, anti-infectives, gastroenterology, nephrology, gynecology, pediatrics, orthopedics, dental, and nutraceutical supplements. The company is positioned as a rapidly growing branded generics player with more than 200 active employees and no proprietary platform technology or clinical-stage assets reported.[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exsiva Pharma.